Explore research on how pharmaceutical companies shape media narratives and government policies
Explore Research View CompaniesJournal of Medical Ethics (2023)
This study examines how pharmaceutical funding affects research outcomes and publication bias.
Research Companies: Pfizer, Johnson & Johnson, Merck
Columbia Journalism Review (2022)
Analysis of how pharmaceutical advertising impacts media coverage of drug efficacy and side effects.
Media Companies: AstraZeneca, GlaxoSmithKline
Journal of Health Politics, Policy and Law (2024)
Examination of the relationship between pharmaceutical lobbying and healthcare legislation.
Government Companies: Pfizer, Eli Lilly, Novartis
BMJ (2023)
Investigation into the revolving door between pharmaceutical companies and regulatory agencies.
Government Companies: Johnson & Johnson, Roche, Bayer
Journal of Medical Internet Research (2021)
Analysis of how pharmaceutical companies use social media to shape public perception.
Media Companies: AbbVie, Bristol Myers Squibb
The Big Pharma Research App aims to compile and present research on pharmaceutical companies' influence on media and government in an accessible, user-friendly format. Our goal is to provide a comprehensive resource for researchers, journalists, policymakers, and the public to better understand the complex relationships between pharmaceutical corporations, media narratives, and government policies.
The research presented in this application is sourced from peer-reviewed academic journals, investigative journalism, government reports, and public data repositories. We prioritize studies that meet rigorous methodological standards and come from reputable sources.
Our data on pharmaceutical companies includes information on:
This application is designed for educational and research purposes only. While we strive for accuracy and objectivity, we encourage users to verify information with primary sources and to consider multiple perspectives on these complex issues.
The research compiled here does not necessarily imply wrongdoing by any specific company or individual. Rather, it aims to illuminate systemic patterns and relationships that may impact public health policy, media coverage, and regulatory decisions.